The pathogenesis of diabetic retinopathy: old concepts and new questions
暂无分享,去创建一个
M. Boulton | J. Cai | J Cai | M Boulton | M. Boulton | J. Cai
[1] G. Viglietto,et al. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[2] L. Feld,et al. Degenerated intramural pericytes ('ghost cells') in the retinal capillaries of diabetic rats. , 1991, Current eye research.
[3] T. Resink,et al. Activation of phospholipase A2 by endothelin in cultured vascular smooth muscle cells. , 1989, Biochemical and biophysical research communications.
[4] E. Kohner,et al. A two-year follow-up study of serum insulinlike growth factor-I in diabetics with retinopathy. , 1989, Metabolism: clinical and experimental.
[5] D. Fulton,et al. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart. , 1998, The Journal of pharmacology and experimental therapeutics.
[6] J. Folkman,et al. Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .
[7] M. Lorenzi,et al. Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats , 1996, Diabetologia.
[8] A. Yoshida,et al. Retinal blood flow alterations during progression of diabetic retinopathy. , 1983, Archives of ophthalmology.
[9] S. Weiss,et al. Insulin-Like Growth Factor-I Is Necessary for Neural Stem Cell Proliferation and Demonstrates Distinct Actions of Epidermal Growth Factor and Fibroblast Growth Factor-2 , 2001, The Journal of Neuroscience.
[10] K. Miyarnoto. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .
[11] V. Roginsky,et al. Superoxide dismutase inhibits lipid peroxidation in micelles. , 2001, Chemistry and physics of lipids.
[12] A. Ljubimov,et al. Basement membrane and growth factor gene expression in normal and diabetic human retinas. , 1999, Current eye research.
[13] L. Cantley,et al. HGF-mediated chemotaxis and tubulogenesis require activation of the phosphatidylinositol 3-kinase. , 1995, The American journal of physiology.
[14] N. Ferrara,et al. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.
[15] C. Ferrario,et al. Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats. , 1998, Journal of cardiovascular pharmacology.
[16] W. Li,et al. Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. , 1999, Cellular and molecular biology.
[17] K. Shimoke,et al. Differences in survival‐promoting effects and intracellular signaling properties of BDNF and IGF‐1 in cultured cerebral cortical neurons , 2001, Journal of neurochemistry.
[18] L. Claesson‐Welsh,et al. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase. , 2001, Experimental cell research.
[19] J. García-Campos,et al. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats. , 1998, European journal of pharmacology.
[20] Yihai Cao,et al. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Flt 1 , 1998, Oncogene.
[21] L. Aiello,et al. Vascular Endothelial Growth Factor Induces Expression of Connective Tissue Growth Factor via KDR, Flt1, and Phosphatidylinositol 3-Kinase-Akt-dependent Pathways in Retinal Vascular Cells* , 2000, The Journal of Biological Chemistry.
[22] Thomas N. Sato,et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.
[23] P. Pratt,et al. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. , 1996, Circulation research.
[24] H. Suzuki,et al. Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes , 1997, Diabetologia.
[25] N. Hotta,et al. Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes. , 2000, Experimental eye research.
[26] N. Morisaki,et al. Migratory and proliferative effect of platelet‐derived growth factor in rabbit retinal endothelial cells: Evidence of an autocrine pathway of platelet‐derived growth factor , 1994, Journal of cellular physiology.
[27] R. Kawamori,et al. Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass-spectrometry in type 2 diabetes to assess polyol pathway activity. , 2001, Diabetes research and clinical practice.
[28] A. Garner. Histopathology of diabetic retinopathy in man , 1993, Eye.
[29] M. Neider,et al. Cystoid macular degeneration in experimental branch retinal vein occlusion. , 1988, Ophthalmology.
[30] B. Williams. Vascular Permeability/Vascular Endothelial Growth Factors: A Potential Role in the Pathogenesis and Treatment of Vascular Diseases , 1996, Vascular medicine.
[31] A. Laties. Central retinal artery innervation. Absence of adrenergic innervation to the intraocular branches. , 1967, Archives of ophthalmology.
[32] D. Faller,et al. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. , 1990, The Journal of clinical investigation.
[33] G. King,et al. d-Alpha-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity. , 1999, Diabetes research and clinical practice.
[34] J. Nourooz-Zadeh,et al. F2 Isoprostanes, Potential Specific Markers of Oxidative Damage in Human Retina , 2000, Ophthalmic Research.
[35] F. Ismail-Beigi,et al. Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. , 2000, Diabetes.
[36] Dajun Yang,et al. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. , 1999, Microvascular research.
[37] S. Oparil,et al. Endothelial dysfunction in the pulmonary vascular bed. , 2000, The American journal of the medical sciences.
[38] Z. Katušić,et al. Superoxide anion is an endothelium-derived contracting factor. , 1989, The American journal of physiology.
[39] S. Ryu,et al. The mechanism of phospholipase C-γ1 regulation , 2000, Experimental & Molecular Medicine.
[40] T. Lüscher,et al. Endothelium-dependent Vasoactive Modulation in the Ophthalmic Circulation , 2001, Progress in Retinal and Eye Research.
[41] H. Kleinman,et al. Scatter factor induces blood vessel formation in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[42] H Ueno,et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. , 1992, Science.
[43] E. Kohner,et al. Serum IGF‐1 Concentration in Diabetic Retinopathy , 1988, Diabetic medicine : a journal of the British Diabetic Association.
[44] M. Lizak,et al. Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells. , 1999, Investigative ophthalmology & visual science.
[45] N. Ferrara,et al. Role of Vascular Endothelial Growth Factor in Regulation of Angiogenesis , 1999 .
[46] I. Morita,et al. Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells. , 1992, Atherosclerosis.
[47] N. Bouck,et al. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[48] G. King,et al. Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. , 1994, The American journal of physiology.
[49] A. Kumagai,et al. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. , 2000, Investigative ophthalmology & visual science.
[50] Y. Chung,et al. IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy. , 1994, Diabetes research and clinical practice.
[51] M. Boulton,et al. Increased expression of placenta growth factor in proliferative diabetic retinopathy. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[52] S. Husain,et al. Endothelin-1 activates p38 mitogen-activated protein kinase and cytosolic phospholipase A2 in cat iris sphincter smooth muscle cells. , 1999, The Biochemical journal.
[53] R. Heller,et al. Nitrovasodilators inhibit thrombin-induced platelet-activating factor synthesis in human endothelial cells. , 1992, Biochemical pharmacology.
[54] S. Moncada,et al. Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets , 1987, British journal of pharmacology.
[55] P. Pratt,et al. Bioassay of an Endothelium-Derived Hyperpolarizing Factor from Bovine Coronary Arteries: Role of a Cytochrome P450 Metabolite , 1998, Journal of Vascular Research.
[56] S. Nicosia,et al. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. , 1994, The American journal of pathology.
[57] R. Michels,et al. Diabetic preretinal membranes. An immunohistochemical study. , 1986, Archives of ophthalmology.
[58] K. Suzuma,et al. Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells* , 1999, The Journal of Biological Chemistry.
[59] P. Braquet,et al. Presence of specific platelet-activating factor binding sites in the rat retina. , 1989, European journal of pharmacology.
[60] Dao-Yi Yu,et al. Proceedings of the Australian Physiological and Pharmacological Society Symposium: Diabetes DIABETIC RETINOPATHY EARLY FUNCTIONAL CHANGES , 2006 .
[61] C. Abrass,et al. Phenotypic Expression of Collagen Types in Mesangial Matrix of Diabetic and Nondiabetic Rats , 1988, Diabetes.
[62] Joan W. Miller,et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.
[63] J. Ji. Pigment epithelium derived factor:a potent inhibitor of angiogenesis , 2002 .
[64] Pamela F. Jones,et al. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.
[65] S. Basili,et al. Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. , 1997, Metabolism: clinical and experimental.
[66] E. Araki,et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.
[67] A. Camm,et al. New class III antiarrhythmic drugs. , 1993, European heart journal.
[68] G. King,et al. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[69] R. Eddy,et al. Identification of a new endothelial cell growth factor receptor tyrosine kinase. , 1991, Oncogene.
[70] Alan W. Stitt,et al. Advanced glycation: an important pathological event in diabetic and age related ocular disease , 2001, The British journal of ophthalmology.
[71] L. Aiello,et al. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. , 2000, Investigative ophthalmology & visual science.
[72] S. Cringle,et al. Overview of studies on metabolic and vascular regulatory changes in early diabetic retinopathy. , 1998, Australian and New Zealand journal of ophthalmology.
[73] H Shimokawa,et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. , 2000, The Journal of clinical investigation.
[74] H. Flynn,et al. Echographic evaluation of a patient with diabetes and dense vitreous hemorrhage: an avulsed retinal vessel may mimic a tractional retinal detachment. , 2001, American journal of ophthalmology.
[75] Marlys Witte,et al. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells , 1998, International journal of cancer.
[76] P. Kubes,et al. Leukocyte-induced vascular protein leakage in cat mesentery. , 1991, The American journal of physiology.
[77] G. Zimmerman,et al. Endothelial cell interactions with granulocytes: tethering and signaling molecules. , 1992, Immunology today.
[78] Philippe Soriano,et al. Growth factor signaling pathways in vascular development , 1999, Oncogene.
[79] T. Yamane,et al. Activation of Human Neutrophil by Cytokine-Activated Endothelial Cells , 2001, Circulation research.
[80] J. Brugge,et al. Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. , 1993, The Journal of biological chemistry.
[81] M. Matsumoto,et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[82] M. Cooper,et al. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[83] T. Nishikawa,et al. Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain , 2000 .
[84] Alan W. Stitt,et al. Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. , 1995, The British journal of ophthalmology.
[85] D. Foreman,et al. VEGF localisation in diabetic retinopathy , 1998, The British journal of ophthalmology.
[86] S. Chakrabarti,et al. Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy , 2000, Diabetes/metabolism research and reviews.
[87] A Mathis,et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. , 1994, Archives of ophthalmology.
[88] K. Tracey,et al. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.
[89] P. Campochiaro,et al. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. , 1999, Investigative ophthalmology & visual science.
[90] T. Lüscher,et al. Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. , 1991, Circulation.
[91] S. Moncada,et al. EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN , 1989, The Lancet.
[92] M. Corada,et al. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. , 1998, Journal of cell science.
[93] W. Li,et al. Retinal capillary pericyte apoptosis in early human diabetic retinopathy. , 1997, Chinese medical journal.
[94] E. F. Kern,et al. Effects of Polyol-Pathway Inhibition and Dietary myo-Inositol on Glomerular Hemodynamic Function in Experimental Diabetes Mellitus in Rats , 1991, Diabetes.
[95] J. Rubin,et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.
[96] H. Hammes,et al. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. , 2001, Diabetes.
[97] M. Matsumura,et al. Epiretinal membrane of proliferative diabetic retinopathy: an immunohistochemical study. , 1993, Ophthalmic research.
[98] F. Ferris,et al. Diabeteslike proliferative retinal changes in galactose-fed dogs. , 1995, Archives of ophthalmology.
[99] M. Nelson,et al. Extracellular K(+)‐induced hyperpolarizations and dilatations of rat coronary and cerebral arteries involve inward rectifier K(+) channels. , 1996, The Journal of physiology.
[100] D. Killilea,et al. Hypoxia promotes oxidative base modifications in the pulmonary artery endothelial cell VEGF gene , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[101] M. Dunlop,et al. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. , 2000, Kidney international. Supplement.
[102] N. Ashton. Retinal vascularization in health and disease: Proctor Award Lecture of the Association for Research in Ophthalmology. , 1957, American journal of ophthalmology.
[103] Paul Kubes,et al. The microcirculation and inflammation: modulation of leukocyte‐endothelial cell adhesion , 1994, Journal of leukocyte biology.
[104] S. Bursell,et al. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. , 1997, American journal of ophthalmology.
[105] H. Bohlen,et al. Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. , 1993, The American journal of physiology.
[106] D. Hinton,et al. Retinal pigment epithelial cells secrete and respond to hepatocyte growth factor. , 1998, Biochemical and biophysical research communications.
[107] K. Nakagawa,et al. The mechanism of thrombin-induced prostacyclin synthesis in human endothelial cells with reference to the gene transcription of prostacyclin-related enzymes and Ca2+ kinetics. , 1999, Journal of pharmacological and toxicological methods.
[108] E. Sage,et al. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors , 1994, The Journal of cell biology.
[109] T. Onat,et al. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control. , 2001, Archives of medical research.
[110] E. Elson,et al. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. , 1989, Science.
[111] L. Aiello,et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.
[112] P. Campochiaro,et al. Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. , 1998, The American journal of pathology.
[113] Y. Yazaki,et al. Vascular Smooth Muscle Cell-Directed Overexpression of Heme Oxygenase-1 Elevates Blood Pressure Through Attenuation of Nitric Oxide-Induced Vasodilation in Mice , 2001, Circulation research.
[114] A. Ceriello. Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications. , 1999, Diabetes, nutrition & metabolism.
[115] R. Khalifah,et al. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions. , 1999, Biochemical and biophysical research communications.
[116] W. Daughaday,et al. Endogenous insulin-like growth factor (IGF) binding proteins cause IGF-1 resistance in cultured fibroblasts from a patient with short stature. , 1991, The Journal of clinical investigation.
[117] J. van de Voorde,et al. Endothelial dysfunction in diabetes , 2000, British journal of pharmacology.
[118] M. Lorenzi,et al. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. , 2001, Diabetes.
[119] M. Shimura,et al. Quantifying leukocyte dynamics and plugging in retinal microcirculation of streptozotosin-induced diabetic rats. , 1999, Current eye research.
[120] R. Busse,et al. Characterization of endothelium‐derived hyperpolarizing factor as a cytochrome P450‐derived arachidonic acid metabolite in mammals. , 1994, The Journal of physiology.
[121] T. Kern,et al. Vascular lesions in diabetes are distributed non-uniformly within the retina , 1995 .
[122] M. Derwahl,et al. Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[123] I. Fleming,et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. , 2000, Trends in cardiovascular medicine.
[124] M. Goldberg,et al. Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*) , 1995, The Journal of Biological Chemistry.
[125] N. Karmakar. Interaction of transmural pressure and shear stress in the transport of albumin across the rabbit aortic wall. , 2001, Atherosclerosis.
[126] M. Li,et al. Enhanced shear-induced von Willebrand factor binding to platelets in acute myocardial infarction. , 2000, Thrombosis research.
[127] J. Erusalimsky,et al. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. , 1995, Circulation.
[128] F. Wen,et al. Eicosanoid profile in cultured human pulmonary artery smooth muscle cells treated with IL-1 beta and TNF alpha. , 1998, Prostaglandins, Leukotrienes and Essential Fatty Acids.
[129] L. Claesson-Welsh,et al. Platelet-derived growth factor receptor signals. , 1994, The Journal of biological chemistry.
[130] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[131] T. Kern,et al. Abnormalities of Retinal Metabolism in Diabetes or Experimental Galactosemia. III. Effects of Antioxidants , 1996, Diabetes.
[132] T. Kern,et al. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. , 1997, Free radical biology & medicine.
[133] G. Brown,et al. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. , 1990, Archives of ophthalmology.
[134] J. Isner,et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. , 1998, Circulation.
[135] D. K. Ways,et al. The role of protein kinase C in the development of the complications of diabetes. , 2000, Vitamins and hormones.
[136] J. Remacle,et al. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. , 2000, Biochimica et biophysica acta.
[137] D. Eliott,et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.
[138] T. Bek,et al. Glycoprotein deposition in vascular walls of diabetic retinopathy. A histopathological and immunohistochemical study. , 2009, Acta ophthalmologica Scandinavica.
[139] S. Narayanan. Aldose reductase and its inhibition in the control of diabetic complications. , 1993, Annals of clinical and laboratory science.
[140] H. Yamashita,et al. Expression of placenta growth factor (PIGF) in ischaemic retinal diseases , 1999, Eye.
[141] L. Cantley,et al. The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. , 1991, The Journal of biological chemistry.
[142] P. Gruppuso,et al. Src family tyrosine kinases participate in insulin-like growth factor I mitogenic signaling in 3T3-L1 cells. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[143] D. Foreman,et al. Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy , 1999, The British journal of ophthalmology.
[144] H. Zhu,et al. Oxygen sensing and signaling: impact on the regulation of physiologically important genes. , 1999, Respiration physiology.
[145] M. Dehouck,et al. Endothelin-1 as a Mediator of Endothelial Cell–Pericyte Interactions in Bovine Brain Capillaries , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[146] H. Oğuz,et al. The role of oxidative stress in diabetic retinopathy , 2000, Eye.
[147] E. Rosen,et al. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[148] J. Folkman,et al. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. , 1989, Biochemistry.
[149] D. Dimitrov,et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. , 1992, Biochemical and biophysical research communications.
[150] S. Ryu,et al. The mechanism of phospholipase C-gamma1 regulation. , 2000, Experimental & molecular medicine.
[151] T. Nakamura,et al. Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signalling pathways mediated by protein kinase C. , 1994, Research communications in molecular pathology and pharmacology.
[152] D. Rye,et al. Somatomedin on insulin-dependent diabetes mellitus. , 1977, The Journal of clinical endocrinology and metabolism.
[153] P. Campochiaro,et al. Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization , 2000, Journal of cellular physiology.
[154] I. Eardley,et al. The effect of cyclic GMP on rabbit corporal smooth muscle tone and its modulation by cyclo-oxygenase products. , 2000, Prostaglandins, leukotrienes, and essential fatty acids.
[155] J. Caro,et al. Hypoxia regulation of gene transcription. , 2001, High altitude medicine & biology.
[156] R. Coleman,et al. Diacylglycerol generated in CHO cell plasma membrane by phospholipase C is used for triacylglycerol synthesis. , 2001, Journal of lipid research.
[157] D. Edwards,et al. Gap junctional communication underpins EDHF-type relaxations evoked by ACh in the rat hepatic artery. , 2001, American journal of physiology. Heart and circulatory physiology.
[158] Lois E. H. Smith,et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. , 1997, Science.
[159] D. Gospodarowicz,et al. Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. , 1989, Endocrinology.
[160] G. Zimmerman,et al. The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C. , 1989, The Journal of biological chemistry.
[161] P. Kubes,et al. Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[162] T. Bek,et al. Foveal haemorrhages in diabetic retinopathy. Clinical characteristics and visual outcome. , 2000, Acta ophthalmologica Scandinavica.
[163] S. Bursell,et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. , 1996, Science.
[164] C. Lundby,et al. Acute hypoxia and hypoxic exercise induce DNA strand breaks and oxidative DNA damage in humans , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[165] J. Matés,et al. Antioxidant enzymes and human diseases. , 1999, Clinical biochemistry.
[166] Minoru Yoshida,et al. Eicosanoid profile in cultured human pulmonary artery smooth muscle cells treated with IL-1β and TNFα , 1998 .
[167] J. Stamler,et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. , 1994, Circulation.
[168] E S Gragoudas,et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. , 1996, Archives of ophthalmology.
[169] J. P. De La Cruz,et al. Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes. , 1998, European journal of pharmacology.
[170] M. Nishikawa,et al. Significance of Platelet-Derived Microparticles and Activated Platelets in Diabetic Nephropathy , 1999, Nephron.
[171] G. Chader. PEDF: Raising both hopes and questions in controlling angiogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[172] T. Lyons,et al. Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. , 1991, Biochemistry.
[173] A. Giaccia,et al. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. , 1997, Blood.
[174] J. Partanen,et al. Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells , 1997, British journal of haematology.
[175] Daniel B. Rifkin,et al. Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis , 1998, The Journal of cell biology.
[176] P. Kubes,et al. Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. , 1993, Gastroenterology.
[177] K. Plate,et al. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. , 1998, The American journal of pathology.
[178] K. Kawasaki,et al. Upregulation of Retinal Vascular Endothelial Growth Factor mRNAs in Spontaneously Diabetic Rats without Ophthalmoscopic Retinopathy , 1998, Ophthalmic Research.
[179] T. Nakamura,et al. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[180] Lois E. H. Smith,et al. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[181] Søren Jacob Bakke,et al. Regional cerebral blood flow (rCBF) and cerebral vasoreactivity in patients with retinal ischaemic symptoms. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[182] G. Paolisso,et al. Oxidative Stress and Diabetic Vascular Complications , 1996, Diabetes Care.
[183] A. Phillips,et al. Decreased Degradation of Collagen and Fibronectin following Exposure of Proximal Cells to Glucose , 1999, Nephron Experimental Nephrology.
[184] M. Aoki,et al. Potential Role of an Endothelium-Specific Growth Factor, Hepatocyte Growth Factor, on Endothelial Damage in Diabetes , 1997, Diabetes.
[185] N. Fausto. Hepatocyte growth factor receptor and the c-met oncogene Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802?804 , 1991 .
[186] L. Rizzolo,et al. Regulation of glucose transporters during development of the retinal pigment epithelium. , 2000, Brain research. Developmental brain research.
[187] Ic. Michaelson,et al. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases , 1948 .
[188] T. Quinn,et al. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[189] H. Zhu,et al. Yeast flavohemoglobin is an ancient protein related to globins and a reductase family. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[190] John Calvin Reed,et al. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. , 2000, The American journal of pathology.
[191] N. Matsuki,et al. Endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[192] L. Levine. Lactacystin stimulates arachidonic acid metabolism in rat liver cells: effects of cell density on arachidonic acid release, PGI2 production and cyclooxygenase activity. , 2000, Prostaglandins, leukotrienes, and essential fatty acids.
[193] M. Shibuya,et al. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. , 1995, Oncogene.
[194] Y. Hirata,et al. The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia. , 1988, Metabolism: clinical and experimental.
[195] G. Camussi,et al. Production of platelet-activating factor by chick retina. , 1986, The Journal of biological chemistry.
[196] S. Bursell,et al. Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.
[197] W. Sessa,et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. , 2001, The American journal of pathology.
[198] G. Werther,et al. Localization of mRNAs for insulin-like growth factor-I (IGF-I), IGF-I receptor, and IGF binding proteins in rat eye. , 1996, Investigative ophthalmology & visual science.
[199] C. Kahn,et al. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. , 1985, The Journal of clinical investigation.
[200] W. Liu,et al. LY 294002, an inhibitor of phosphatidylinositol 3-kinase, inhibits GH-mediated expression of the IGF-I gene in rat hepatocytes. , 2001, Endocrinology.
[201] Y. Hinokio,et al. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications , 1999, Diabetologia.
[202] H. Tritschler,et al. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy. , 1999, Diabetes.
[203] T. Kern,et al. Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione. , 1994, Investigative ophthalmology & visual science.
[204] E. Feldman,et al. The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. , 1994, The Journal of clinical investigation.
[205] G. Zimmerman,et al. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. , 1985, The Journal of clinical investigation.
[206] P. Vanhoutte,et al. Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-L-arginine in rats. , 1992, The American journal of physiology.
[207] G. Schmid-Schönbein,et al. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. , 1991, The American journal of pathology.
[208] J. Simons,et al. Hypoxia-inducible factor 1α and 1β proteins share common signaling pathways in human prostate cancer cells , 2001 .
[209] M. Boulton,et al. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management , 1997, The British journal of ophthalmology.
[210] M. Shibuya,et al. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts , 1997, Oncogene.
[211] V. Han,et al. Modulation of insulin-like growth factor (IGF) and IGF binding protein biosynthesis by hypoxia in cultured vascular endothelial cells. , 1998, The Journal of endocrinology.
[212] T. Nakamura,et al. Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[213] E. Leite,et al. Blood-retinal barrier permeability and its relation to progression of retinopathy in patients with type 2 diabetes. A four-year follow-up study , 1993, Graefe's Archive for Clinical and Experimental Ophthalmology.
[214] D. Granger,et al. Role of adhesion molecules in vascular regulation and damage , 2000, Current hypertension reports.
[215] R. Wallace,et al. Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-alpha and phorbol myristate acetate. , 1992, The Journal of biological chemistry.
[216] E. Kohner,et al. Intracellular protein glycation in cultured retinal capillary pericytes and endothelial cells exposed to high-glucose concentration. , 1999, Cellular and molecular biology.
[217] S. Coughlin,et al. Signal transduction by the platelet-derived growth factor receptor. , 1988, Cold Spring Harbor symposia on quantitative biology.
[218] E. Agardh,et al. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats. , 2000, Current eye research.
[219] D. Greene,et al. Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells. , 1993, The American journal of physiology.
[220] T. Lane,et al. Modulation of endothelial cell expression of intercellular adhesion molecule 1 by protein kinase C activation. , 1989, Biochemical and biophysical research communications.
[221] S. Sakakibara,et al. Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. , 1988, Biochemical and biophysical research communications.
[222] K. Sugahara,et al. Inhibition of activation of human peripheral blood eosinophils by Y-24180, an antagonist to platelet-activating factor receptor. , 1999, Life sciences.
[223] H. Granger,et al. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[224] J. Cunha-Vaz,et al. The blood-retinal barrier in diabetes during puberty. , 1994, Archives of ophthalmology.
[225] J. E. Poulsen. The Houssay Phenomenon in Man: Recovery from Retinopathy in a Case of Diabetes With Simmonds' Disease , 1953, Diabetes.
[226] H. Freyberger,et al. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. , 1993, The Journal of clinical investigation.
[227] S. Husain,et al. Role of protein kinase C alpha and mitogen-activated protein kinases in endothelin-1-stimulation of cytosolic phospholipase A2 in iris sphincter smooth muscle. , 2000, Journal of cardiovascular pharmacology.
[228] J. Smith,et al. Prostaglandin E2‐induced sensitization of bradykinin‐evoked responses in rat dorsal root ganglion neurons is mediated by cAMP‐dependent protein kinase A , 2000, The European journal of neuroscience.
[229] K. Kato,et al. VEGF-dependent signaling in retinal microvascular endothelial cells. , 1999, Fukushima journal of medical science.
[230] B Kirchhof,et al. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.
[231] Alan W. Stitt,et al. Expression of the VEGF gene family during retinal vaso-obliteration and hypoxia. , 1999, Biochemical and biophysical research communications.
[232] Y. Neuman,et al. Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction: possible implications for leukocyte aggregation and microvascular plugging. , 1998, Journal of the American College of Cardiology.
[233] S. Nomura,et al. Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation. , 2000, Cytometry.
[234] R. Simó,et al. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. , 2000, Diabetes care.
[235] J. Tombran-Tink,et al. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. , 1991, Experimental eye research.
[236] M. Itoh,et al. Exogenous Nitric Oxide Increases Neutrophil Adhesion to Cultured Human Endothelial Monolayers through a Protein Kinase G Dependent Mechanism , 1999, Inflammation.
[237] Pamela F. Jones,et al. Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.
[238] R. Levy,et al. Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. , 2001, The American journal of pathology.
[239] T. Kern,et al. Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia. , 1996, Archives of ophthalmology.
[240] L. Giudice,et al. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[241] R. Tarnuzzer,et al. Insulin-like growth factor: receptor and binding proteins in human retinal endothelial cell cultures of diabetic and non-diabetic origin. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[242] L. Aiello,et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[243] M. Grant,et al. Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor , 1993, Diabetologia.
[244] J. Flanagan,et al. Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth Factor , 1996, The Journal of Biological Chemistry.
[245] K. Shin,et al. Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin‐induced diabetic rat tissues , 2001, The Journal of pharmacy and pharmacology.
[246] D. Maglione. Persico MG.Isolation of a human placenta cDNA coding for a potein related to the vascular premeability factor , 1991 .
[247] K. Preissner,et al. Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. , 1995, Experimental eye research.
[248] N. Copeland,et al. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[249] C. Heldin,et al. Rat brain capillary endothelial cells express functional PDGF B-type receptors. , 1989, Growth factors.
[250] R. Kaufmann,et al. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. , 1998, The Journal of investigative dermatology.
[251] M. Nomura,et al. Placenta Growth Factor and Vascular Endothelial Growth Factor B and C Expression in Microvascular Endothelial Cells and Pericytes , 1999, The Journal of Biological Chemistry.
[252] S. Husain,et al. Role of protein kinase Cα and mitogen-activated protein kinases in endothelin-1-stimulation of cytosolic phospholipase A2 in iris sphincter smooth muscle , 2000 .
[253] J. Alexander,et al. Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins* , 1998, The Journal of Biological Chemistry.
[254] A. Ullrich,et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis , 1993, Cell.
[255] M. Shibuya,et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. , 1990, Oncogene.
[256] M. Burns,et al. Retinal vessel abnormalities of phototoxic retinopathy in rats. , 1980, Investigative ophthalmology & visual science.
[257] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[258] F. Ferris,et al. Diabeteslike proliferative retinal changes in galactose-fed dogs , 1993 .
[259] Carter Vb,et al. The power of words. , 1951, Lancet.
[260] E. Agardh,et al. The glutathione levels are reduced in Goto-Kakizaki rat retina, but are not influenced by aminoguanidine treatment. , 1998, Current eye research.
[261] M. Triggiani,et al. Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine. , 1999, Biochemical pharmacology.
[262] H. Drexler,et al. Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines. , 1998, Leukemia research.
[263] J. P. De La Cruz,et al. Effect of erythrocytes and prostacyclin production in the effect of fructose and sorbitol on platelet activation in human whole blood in vitro. , 1997, Thrombosis research.
[264] U. Pohl,et al. Endothelium-derived nitric oxide in the control of tissue perfusion and oxygen supply: physiological and pathophysiological implications. , 1993, European heart journal.
[265] C. Heldin,et al. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[266] D. Gospodarowicz,et al. VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. , 1994, Growth factors.
[267] L. Aiello,et al. Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor. , 2000, The Journal of clinical investigation.
[268] M. Boulton,et al. Production of IGF-I and IGF binding proteins by retinal cells in vitro. , 1994, The British journal of ophthalmology.
[269] M. Rusnati,et al. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form , 1989, Journal of cellular physiology.
[270] S. Iannello,et al. In vitro inhibition of glucose phosphorylation by an aldose-reductase inhibitor (Tolrestat) in some non-insulin-sensitive rabbit tissues. , 1999, Journal of diabetes and its complications.
[271] Urban Deutsch,et al. Angiopoietin-1 induces sprouting angiogenesis in vitro , 1998, Current Biology.
[272] T. Miyahara,et al. Endothelin-1 selectively contracts portal vein through both ETA and ETB receptors in isolated rabbit liver. , 1997, The American journal of physiology.
[273] R. Palmer,et al. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[274] M. Shibuya,et al. A single autophosphorylation site on KDR/Flk‐1 is essential for VEGF‐A‐dependent activation of PLC‐γ and DNA synthesis in vascular endothelial cells , 2001, The EMBO journal.
[275] P. Campochiaro,et al. Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularization , 2001, Journal of cellular physiology.